|
Volumn 8, Issue 4, 2005, Pages 269-271
|
Therapeutic implications of intrinsic or induced angiogenic growth factor redundancy in tumors revealed
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
GROWTH FACTOR;
VASCULOTROPIN RECEPTOR;
VATALANIB;
ANGIOGENESIS;
CANCER STAGING;
CHEMOTHERAPY;
CLINICAL TRIAL;
HUMAN;
HYPOXIA;
MONOTHERAPY;
MUTATION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PHOSPHORYLATION;
SENSITIZATION;
SHORT SURVEY;
SURVIVAL;
TUMOR;
TUMOR CELL;
|
EID: 26644465301
PISSN: 15356108
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ccr.2005.09.016 Document Type: Short Survey |
Times cited : (58)
|
References (14)
|